Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2026)

Nuwellis' (NUWE) quarterly Amortization of Deferred Charges came in at $6.1 million in Q2 2026, down 42.41% on a YoY basis from $10.6 million in Q2 2025, and down 42.41% quarter-over-quarter from $10.6 million in Q2 2025.

Analysis

Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Amortization of Deferred Charges for 4 consecutive years, with $6.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization of Deferred Charges fell 42.41% year-over-year to $6.1 million; the trailing twelve-month figure through Jun 2026 stood at $16.6 million (up 2.91% YoY), and the FY2025 full-year result was $10.6 million, up 88.21% from the prior year.
  • Amortization of Deferred Charges slipped to $6.1 million in Q2 2026 per NUWE's latest filing, from $10.6 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $10.6 million in Q2 2025 and bottomed at $3.5 million in Q4 2023.
  • Historically, Amortization of Deferred Charges has averaged $6.4 million across 4 years, with a median of $5.8 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges jumped 88.21% in 2025, then sank 42.41% in 2026.
  • Over 4 years, Amortization of Deferred Charges stood at $3.5 million in 2023, then surged by 60.98% to $5.6 million in 2024, then soared by 88.21% to $10.6 million in 2025, then tumbled by 42.41% to $6.1 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $6.1 million, $10.6 million, and $5.6 million for Q2 2026, Q2 2025, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.08 Mn
Jun 30, 2025 10.55 Mn
Jun 30, 2024 5.61 Mn
Dec 31, 2023 3.48 Mn